NO20033184L - Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol - Google Patents

Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol

Info

Publication number
NO20033184L
NO20033184L NO20033184A NO20033184A NO20033184L NO 20033184 L NO20033184 L NO 20033184L NO 20033184 A NO20033184 A NO 20033184A NO 20033184 A NO20033184 A NO 20033184A NO 20033184 L NO20033184 L NO 20033184L
Authority
NO
Norway
Prior art keywords
piperidinemethanol
dimethoxyphenyl
fluorophenyl
alpha
ethyl
Prior art date
Application number
NO20033184A
Other languages
English (en)
Other versions
NO20033184D0 (no
Inventor
Cesare Mondadori
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20033184L publication Critical patent/NO20033184L/no
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20033184D0 publication Critical patent/NO20033184D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20033184A 1996-03-21 2003-07-11 Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol NO20033184D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96400591A EP0796619A1 (en) 1996-03-21 1996-03-21 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
PCT/US1997/002597 WO1997034603A1 (en) 1996-03-21 1997-02-21 USE OF (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL IN TREATING DEPRESSIVE DISORDERS AND BIPOLAR DISORDERS

Publications (2)

Publication Number Publication Date
NO20033184L true NO20033184L (no) 1998-09-18
NO20033184D0 NO20033184D0 (no) 2003-07-11

Family

ID=8225234

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19984348A NO316788B1 (no) 1996-03-21 1998-09-18 Anvendelse av (+)-<alfa>-(2,3-dimethoxyfenyl)-1-[2-(4-fluorfenyl)-ethyl]-4-piperidinmethanol ved behandling av depressive sykdommer
NO20033184A NO20033184D0 (no) 1996-03-21 2003-07-11 Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19984348A NO316788B1 (no) 1996-03-21 1998-09-18 Anvendelse av (+)-<alfa>-(2,3-dimethoxyfenyl)-1-[2-(4-fluorfenyl)-ethyl]-4-piperidinmethanol ved behandling av depressive sykdommer

Country Status (23)

Country Link
US (2) US6022877A (no)
EP (2) EP0796619A1 (no)
JP (1) JP4165906B2 (no)
KR (1) KR100423018B1 (no)
CN (1) CN1114406C (no)
AR (1) AR006281A1 (no)
AT (1) ATE219672T1 (no)
AU (1) AU704435B2 (no)
BR (1) BR9708109A (no)
CA (1) CA2250077C (no)
DE (1) DE69713571T2 (no)
DK (1) DK0888114T3 (no)
ES (1) ES2175356T3 (no)
HK (1) HK1019702A1 (no)
HU (1) HU226675B1 (no)
IL (1) IL126022A (no)
NO (2) NO316788B1 (no)
NZ (1) NZ331448A (no)
PT (1) PT888114E (no)
SI (1) SI0888114T1 (no)
TW (1) TW517048B (no)
WO (1) WO1997034603A1 (no)
ZA (1) ZA972345B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796619A1 (en) * 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
TWI249526B (en) * 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US6277864B1 (en) 1998-08-28 2001-08-21 Aventis Pharmaceuticals Inc. Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders
DE69911436T2 (de) * 1998-08-28 2004-07-01 Aventis Pharmaceuticals Inc. Die verwendung von r (+)- g(a)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol zur behandlung von obstruktive schlafapnoe
US6939879B2 (en) 1998-08-28 2005-09-06 Aventis Pharmaceuticals Inc. Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia
US20020099076A1 (en) * 2000-05-25 2002-07-25 Richard Scheyer D. Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
US20020161026A1 (en) * 2000-11-07 2002-10-31 Paralkar Vishwas M. Combination therapies for the stimulation of bone growth
DE60113731T2 (de) * 2001-01-31 2006-06-29 Pfizer Products Inc., Groton Als inhibitoren von pde4-isozymen geeignete etherderivate
US8501778B2 (en) 2008-06-20 2013-08-06 Nhwa Pharma. Corporation Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
US8188119B2 (en) * 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169096A (en) * 1985-07-02 1992-12-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl-piperidine-methanol derivatives
US4783471A (en) * 1985-07-02 1988-11-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine methanol derivatives and the uses thereof
US4912117A (en) * 1985-07-02 1990-03-27 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds
US5021428A (en) * 1985-07-02 1991-06-04 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds for the prophylactic treatment of migraine
US4762842A (en) * 1985-10-01 1988-08-09 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4877798A (en) * 1987-11-23 1989-10-31 Merrell Dow Pharmaceuticals Inc. Treatment of fibromyalgia
JPH02138214A (ja) * 1987-12-10 1990-05-28 Merrell Dow Pharmaceut Inc 不安を治療する方法
ATE102482T1 (de) * 1988-01-21 1994-03-15 Merrell Dow Pharma Verwendung von 1,4-disubstituierten-piperidinyl- verbindungen zur herstellung eines arzneimittels zur behandlung von schlaflosigkeit.
US5064838A (en) * 1988-01-21 1991-11-12 Merrell Dow Pharmaceuticals 1,4-disubstituted-piperidinyl compounds as pain relievers
ZA891901B (en) * 1988-03-17 1989-11-29 Merrell Dow Pharma Method for the treatment of the extrapyramidal side effects associated with neuroleptic therapy
US4902691A (en) * 1988-12-19 1990-02-20 Eli Lilly And Company Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors
US5106855A (en) * 1989-12-20 1992-04-21 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
DE69105501T2 (de) * 1990-06-01 1995-04-13 Merrell Dow Pharma (+)-alpha-(2,3 dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinmethanol.
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
HUP9903684A3 (en) * 1995-12-22 2001-12-28 Lilly Co Eli Use of olanzapine for the preparation of pharmaceutical compositions treating depression
EP0796619A1 (en) * 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders

Also Published As

Publication number Publication date
IL126022A (en) 2003-11-23
CN1213968A (zh) 1999-04-14
DE69713571T2 (de) 2003-02-20
HU226675B1 (en) 2009-06-29
CA2250077C (en) 2003-10-07
US6022877A (en) 2000-02-08
CN1114406C (zh) 2003-07-16
ZA972345B (en) 1997-09-25
NO984348L (no) 1998-09-18
JP4165906B2 (ja) 2008-10-15
KR20000064711A (ko) 2000-11-06
KR100423018B1 (ko) 2004-05-17
IL126022A0 (en) 1999-05-09
NO20033184D0 (no) 2003-07-11
ES2175356T3 (es) 2002-11-16
DK0888114T3 (da) 2002-10-07
NZ331448A (en) 2000-06-23
NO316788B1 (no) 2004-05-10
JP2000506887A (ja) 2000-06-06
AR006281A1 (es) 1999-08-11
BR9708109A (pt) 1999-07-27
EP0888114B1 (en) 2002-06-26
CA2250077A1 (en) 1997-09-25
TW517048B (en) 2003-01-11
DE69713571D1 (de) 2002-08-01
HUP9902135A2 (hu) 1999-11-29
ATE219672T1 (de) 2002-07-15
US6380216B1 (en) 2002-04-30
HUP9902135A3 (en) 2001-05-28
AU704435B2 (en) 1999-04-22
EP0796619A1 (en) 1997-09-24
HK1019702A1 (en) 2000-02-25
EP0888114A1 (en) 1999-01-07
PT888114E (pt) 2002-11-29
WO1997034603A1 (en) 1997-09-25
NO984348D0 (no) 1998-09-18
AU1963197A (en) 1997-10-10
SI0888114T1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
BR9707411A (pt) Composição dental polimerizável e composto polmerizável
AU6613896A (en) Chemical compounds
DK1109812T3 (da) Pyrrolobenzodiazepiner
ID17553A (id) Bentuk-bentuk padatan dosis oral
DE69607178D1 (de) Mikroemulsionsförmige Desinfektionszusammensetzung
BR9707501A (pt) Composto composição farmacêutica e uso do composto
HK1099197A1 (en) Use of interferon gamma for the treatment of cardiac hypertrophy
NO20033184L (no) Anvendelse av forbindelsen (+)-&lt;alfa&gt;-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
PL311266A1 (en) Application of indole derivatives as 5ht1 antagonists
NO20004545L (no) FremgangsmÕte for fremstilling av (R)-&lt;alfa&gt;-(2,3- dimetoksyfenyl)-1-[2-(4-fluorofenyl)etyl]-4-piperidinmetanol
FI955118A (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
IT1269916B (it) Procedimento migliorato per la sintesi di dimetilcarbonato
CA2427573A1 (en) Indole derivatives as pde5-inhibitors
AU4712696A (en) The use of heterocyclic compounds
DE69715032D1 (de) Kosmetische antitraspirant zusammensetzung
NO20011805D0 (no) Estere av (+)-&lt;alfa&gt;-(3,2-dimetoksyfenyl)-1-((2-(4- fluorfenyl)etyl)-4-piperidinmetanol) og deres anvendelse somprodrugs for 5HT2A-reseptorantagonist MDL 110.907
ZA974679B (en) New use of derivatives of cystine.
AU6196599A (en) Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for theproduction thereof and agents containing the same
HUP0202145A3 (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
IT1320401B1 (it) Procedimento per la fabbricazione di componenti di un&#39;ossatura ecomponenti di ossatura.
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
BR1100532A (pt) (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorfenil)etil]-4-pipe ridinometanol e composição contendo o mesmo
ES2149691A1 (es) 2-4-[4-(4,5-dicloro-2metilimidazol-1-il)butil]-1-piperacinil -5-fluoropirimidina, su preparacion y su utilizacion terapeutica.
IL158978A (en) Salts and solvates of the compound (+)-(2s,3s)-2-(3-chlorophenyl) -3,5,5- trimethyl-2-morpholinol
IT1282582B1 (it) Procedimento per la preparazione di perossido di idrogeno

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application